3DBio Therapeutics Announces Appointment of Sol Barer, Ph.D. and Kevin Slawin, M.D. to Board of Directors
Leave reply:
This site uses Akismet to reduce spam. Learn how your comment data is processed.
Follow Kairos Ventures on LinkedIn
Subscribe to Kairos News
Recent Posts
- Trial to Test Whether Drug that Targets Gut Bacteria Can Improve Irritability in Teenagers with Autism
- Vivodyne Announces New Chief Commercial Officer
- Sivers Semiconductors Signs $16.4 Million Strategic Development Agreement with European Satellite Communications Company
- Popular Science Most Powerful Health Innovations of 2022 – Grand Award Winner: AuriNova by 3DBio Therapeutics
- Sienza Energy Develops European HQ in Luxembourg